These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7692047)

  • 1. Discovery and synthesis of methyl 2,5-dimethyl-4-[2- (phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylate (FPL 64176) and analogues: the first examples of a new class of calcium channel activator.
    Baxter AJ; Dixon J; Ince F; Manners CN; Teague SJ
    J Med Chem; 1993 Sep; 36(19):2739-44. PubMed ID: 7692047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
    Usowicz MM; Gigg M; Jones LM; Cheung CW; Hartley SA
    J Pharmacol Exp Ther; 1995 Nov; 275(2):638-45. PubMed ID: 7473149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
    Rampe D; Anderson B; Rapien-Pryor V; Li T; Dage RC
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1125-30. PubMed ID: 7685384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RS 30026: a potent and effective calcium channel agonist.
    Patmore L; Duncan GP; Clarke B; Anderson AJ; Greenhouse R; Pfister JR
    Br J Pharmacol; 1990 Apr; 99(4):687-94. PubMed ID: 1694461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacological model for calcium overload-induced tachycardia in isolated rat left atria.
    Wolkowicz PE; Grenett HE; Huang J; Wu HC; Ku DD; Urthaler F
    Eur J Pharmacol; 2007 Dec; 576(1-3):122-31. PubMed ID: 17803989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design of (-)-(S)-2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl) pyridine-5-carboxylate: a cardioselective positive inotropic derivative of Bay K 8644.
    Shan R; Knaus EE
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2613-4. PubMed ID: 10498219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A search for calcium-channel activators in the verapamil series.
    Romanelli MN; Gualtieri F; Mannhold R; Chiarini A
    Farmaco; 1989 May; 44(5):449-64. PubMed ID: 2476997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-py rid ine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells.
    Sen N; Wu AM; Spitzer AR; Chander A
    Biochem Pharmacol; 1997 May; 53(9):1307-13. PubMed ID: 9214691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-dihydropyridine L-type voltage-sensitive calcium channel activator FPL 64176 enhances K(+)-evoked efflux of [3H]norepinephrine from rat neocortical slices.
    Ginap T; Dooley DJ; Feuerstein TJ
    Neurosci Lett; 1993 Jun; 156(1-2):35-8. PubMed ID: 7692363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
    Barrús MT; Reviriego J; Marín J
    J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the effects of a new Ca2+ channel activator, FPL 64176, in GH3 cells.
    Kunze DL; Rampe D
    Mol Pharmacol; 1992 Oct; 42(4):666-70. PubMed ID: 1279375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of myocardial economy and efficiency in mammalian failing and non-failing myocardium by calcium channel activation and beta-adrenergic stimulation.
    Ruf T; Hebisch S; Gross R; Alpert N; Just H; Holubarsch C
    Cardiovasc Res; 1996 Dec; 32(6):1047-55. PubMed ID: 9015407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of three structurally distinct Ca2+ channel activators with single L-type Ca2+ channels.
    Lauven M; Handrock R; Müller A; Hofmann F; Herzig S
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):122-8. PubMed ID: 10494880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interactions between two Ca2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle.
    Rampe D; Dage RC
    Mol Pharmacol; 1992 Apr; 41(4):599-602. PubMed ID: 1373795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.